XeroThera's Seed Round

XeroThera raised a round of funding on November 16, 2017. Investors include Ben Franklin Technology Partners of Southeastern PA.

XeroThera focuses on orthopedic and resistant infections and has developed technologies for tissue engineering and the controlled and targeted delivery of drugs and biological molecules. XeroSyn, one …

Articles about XeroThera's Seed Round: